On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion.
Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar-day volume-weighted average price (VWAP) ending December 4, 2024 (the last trading day before Patterson announcing the evaluation of strategic alternatives).
Also Read: Patterson CEO Blames Q1 Drag On Change Healthcare Cyberattack, ‘Timing Of Corporate Expenses’
During its second-quarter earnings release, the company announced it is exploring strategic options, including a sale or merger, to boost shareholder value.
Earnings were mixed, “given the challenging end market environment,” said Patterson CEO Don Zurbay.
The company’s Board of Directors, excluding Zurbay given his position as a Management Director, has unanimously approved the transaction.
Consistent with the Patterson Companies’ commitment to strong governance practices, Zurbay has recused himself from participating in any deliberations or approvals related to the transaction.
The transaction will be financed through a combination of committed equity financing.
The transaction is expected to close in the fourth quarter of Patterson’s fiscal 2025
Upon completion of the transaction, Patterson will become a privately held company, and its common stock will no longer be traded on the NASDAQ.
Patterson will maintain its headquarters in St. Paul, Minnesota.
Price Action: PDCO stock is up 34.8% at $31.15 at the last check on Wednesday.
Read Next:
Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.
Get the latest stock analysis from Benzinga?
This article Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion Deal originally appeared on Benzinga.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。